Fortress Biotech Inc

NASDAQ:FBIO   4:00:00 PM EDT
0.66
+0.01 (+1.72%)
7:07:37 PM EDT: $0.69 +0.03 (+4.99%)
Earnings Announcements

Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results

Published: 11/08/2022 23:24 GMT
Fortress Biotech Inc (FBIO) - Checkpoint Therapeutics Inc Qtrly Net Loss $0.12 per Share.
Revenue is expected to be $19.72 Million
Adjusted EPS is expected to be -$0.15

Next Quarter Revenue Guidance is expected to be $22.85 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.